FIRST-IN-HUMAN OPEN-LABEL MULTICENTRE CLINICAL TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF EPICARDIAL IMPLANTATION OF COLLAGEN MEMBRANES WITH ALLOGENEIC ADIPOSE-DERIVED STEM CELLS IN PATIENTS WITH ISCHAEMIC LEFT VENTRICULAR DYSFUNCTION SCHEDULED TO UNDERGO CORONARY REVASCULARISATION SURGERY

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-517738-16-00

Acronym

CARDIOMESH II

Enrollment

Registered

2024-11-05

Start date

Unknown

Completion date

2025-10-01

Last updated

2025-04-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ventricular failure caused by ischemic heart disease

None listed

Sex/Gender

All

Age

18 Years to No maximum

Poland

None listed

Source: EU CTIS · Data processed: Feb 4, 2026